Enable Injections Inc - Product Pipeline Analysis, 2025 Update

Summary

Enable Injections Inc (Enable Injections) is a healthcare company that develops and manufactures drug delivery systems. It offers enFuse, a wearable delivery system that consists of the enFuse paired with a transfer system option. It also offers syringe transfer system, vial transfer system and dual vial transfer system. Enable Injections Smart enFuse is in development for compatibility with digital infrastructure, enabling data storage and communication capability. Its partners include Apellis Pharmaceuticals, CSL Behring, Sanofi, Roche and Genentech and Viridian Therapeutics. Enable Injections is headquartered in Cincinnati, Ohio, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Enable Injections Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


Enable Injections Inc Company Overview
Enable Injections Inc Company Snapshot
Enable Injections Inc Pipeline Products and Ongoing Clinical Trials Overview
Enable Injections Inc – Pipeline Analysis Overview
Enable Injections Inc - Key Facts
Enable Injections Inc - Major Products and Services
Enable Injections Inc Pipeline Products by Development Stage
Enable Injections Inc Ongoing Clinical Trials by Trial Status
Enable Injections Inc Pipeline Products Overview
Enfuse Differentiated Molecular Drug Delivery System
Enfuse Differentiated Molecular Drug Delivery System Product Overview
enFuse Dual Vial Transfer System
enFuse Dual Vial Transfer System Product Overview
enFuse On-Body Infusor
enFuse On-Body Infusor Product Overview
enFuse Syringe Transfer System
enFuse Syringe Transfer System Product Overview
enFuse Vial Transfer System
enFuse Vial Transfer System Product Overview
Enfuse with SER-252
Enfuse with SER-252 Product Overview
Enfuse with SER-252 Clinical Trial
Enable Injections Inc - Key Competitors
Enable Injections Inc - Key Employees
Enable Injections Inc - Locations And Subsidiaries
Head Office
Recent Developments
Enable Injections Inc, Recent Developments
Apr 25, 2025: Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025
Mar 26, 2025: Enable Injections’ syringe transfer system gains CE mark approval
Jan 09, 2025: New Sarclisa Subcutaneous Formulation Met Co-primary Endpoints in the IRAKLIA Phase 3 Study in Multiple Myeloma
Sep 12, 2024: Enable Injections Announces Agreement with Sobi to Develop and Distribute Aspaveli in Combination with Enfuse in Sobi Territories
May 07, 2024: Enable Injections Expands Strategic Partnership with Roche
Feb 14, 2024: Enable Injections Announces Plans to Expand Manufacturing Facilities and Corporate Headquarters
Nov 07, 2023: Enable Injections Enhances Board with Addition of Vickie Capps
Oct 02, 2023: Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval
May 08, 2023: Viridian Therapeutics announces partnership with drug delivery innovator Enable Injections
Sep 08, 2020: Enable Injections announces $25 million credit facility closed with Oxford Finance
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Enable Injections Inc Pipeline Products and Ongoing Clinical Trials Overview
Enable Injections Inc Pipeline Products by Equipment Type
Enable Injections Inc Pipeline Products by Indication
Enable Injections Inc Ongoing Clinical Trials by Trial Status
Enable Injections Inc, Key Facts
Enable Injections Inc, Major Products and Services
Enable Injections Inc Number of Pipeline Products by Development Stage
Enable Injections Inc Pipeline Products Summary by Development Stage
Enable Injections Inc Ongoing Clinical Trials by Trial Status
Enable Injections Inc Ongoing Clinical Trials Summary
Enfuse Differentiated Molecular Drug Delivery System - Product Status
Enfuse Differentiated Molecular Drug Delivery System - Product Description
enFuse Dual Vial Transfer System - Product Status
enFuse Dual Vial Transfer System - Product Description
enFuse On-Body Infusor - Product Status
enFuse On-Body Infusor - Product Description
enFuse Syringe Transfer System - Product Status
enFuse Syringe Transfer System - Product Description
enFuse Vial Transfer System - Product Status
enFuse Vial Transfer System - Product Description
Enfuse with SER-252 - Product Status
Enfuse with SER-252 - Product Description
Enfuse with SER-252 - A Study to Evaluate the Efficacy of Enable Enfuse with SER-252 in Subjects with Parkinson’s Disease
Enable Injections Inc, Key Employees
Glossary
List of Figures
Enable Injections Inc Pipeline Products by Equipment Type
Enable Injections Inc Pipeline Products by Development Stage
Enable Injections Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings